celgene corporation stock price 2018


Celgene is a biopharmaceutical company that I analyze to see if it is worth for me to invest in. I compare it to other drug makers and try to explain why Celgene …

Celgene CEO Mark Alles on the company’s acquisition of Impact Biomedicines and the future of biotech and drug innovation.

TheStreet’s founder and Action Alerts PLUS Portfolio Manager Jim Cramer weighs in on today’s trending stocks. Want more exclusive investing insight from Jim …

Wall Street Journal global economics editor Jon Hilsenrath and Rosecliff CEO Mike Murphy on Celgene’s deal to acquire Juno Therapeutics.

The “Halftime Report” traders give their top stocks to watch for the second half.






Stock Information – Celgene Corporation

Leave a Reply

Your email address will not be published. Required fields are marked *